BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 16616394)

  • 1. Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer.
    Robles AI; Harris CC
    Lung Cancer; 2017 May; 107():50-58. PubMed ID: 27344275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Results of Lung Cancer Screening and Radiation Dose Assessment by Low-dose CT at a Community Hospital.
    Jacobs CD; Jafari ME
    Clin Lung Cancer; 2017 Sep; 18(5):e327-e331. PubMed ID: 28237242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated impact of LDCT-identified stage IA non-small-cell lung cancer on screening efficacy.
    Reich JM
    Lung Cancer; 2006 Jun; 52(3):265-71. PubMed ID: 16616394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT in non-small cell lung cancer staging-promises and problems.
    Devaraj A; Cook GJ; Hansell DM
    Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT screening for lung cancer: past and ongoing studies.
    Henschke CI; Shaham D; Yankelevitz DF; Altorki NK
    Semin Thorac Cardiovasc Surg; 2005; 17(2):99-106. PubMed ID: 16087075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CT screening for lung cancer.
    Henschke CI; Yankelevitz DF; Altorki NK
    Thorac Surg Clin; 2007 May; 17(2):137-42. PubMed ID: 17626392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Occult mediastinal node involvement in non-small cell lung cancer after negative uptake on PET/CT: ripples through staging and therapy. Case report and critical review].
    Trodella L; Salvati F; Martelli M; Mattia P; Graziano P; Ippolito E
    Clin Ter; 2011; 162(6):559-61. PubMed ID: 22262330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective use of low-dose computed tomography lung cancer screening.
    Jeffers CD; Pandey T; Jambhekar K; Meek M
    Curr Probl Diagn Radiol; 2013; 42(5):220-30. PubMed ID: 24070715
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.